Dynamic, contrast‐enhanced perfusion MRI in mouse gliomas: Correlation with histopathology

The aim of this study was to develop an MRI protocol to evaluate the growth and vascularity of implanted GL261 mouse gliomas on a 7T microimaging system. Both conventional T1‐ and T2‐weighted imaging and dynamic, contrast‐enhanced T2*‐weighted imaging were performed on 34 mice at different stages of tumor development. MRI measurements of relative cerebral blood volume (rCBV) were compared to histological assessments of microvascular density (MVD). Enhancement on postcontrast T1‐weighted images was compared to histological assessments of Evan's blue extravasation. Conventional T2‐weighted and postcontrast T1‐weighted images demonstrated tumor growth characteristics consistent with previous descriptions of GL261 glioma. Furthermore, measurements of rCBV from MRI data were in good agreement with histological measurements of MVD from the same tumors. Postcontrast enhancement on T1‐weighted images was observed at all stages of GL261 glioma progression, even before evidence of angiogenesis, indicating that the mechanism of conventional contrast enhancement in MRI does not require neovascularization. These results provide quantitative support for MRI approaches currently used to assess human brain tumors, and form the basis for future studies of angiogenesis in genetically engineered mouse brain tumor models. Magn Reson Med 49:848–855, 2003. © 2003 Wiley‐Liss, Inc.

[1]  S. Brem.  The role of vascular proliferation in the growth of brain tumors. , 1976, Clinical neurosurgery.

[2]  B. Rosen,et al.  Perfusion imaging with NMR contrast agents , 1990, Magnetic resonance in medicine.

[3]  V. Puduvalli,et al.  Antiangiogenesis – Therapeutic Strategies and Clinical Implications for Brain Tumors , 2000, Journal of Neuro-Oncology.

[4]  J. Folkman,et al.  Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma. , 1991, The New England journal of medicine.

[5]  J. Folkman,et al.  Tumor angiogenesis: a quantitative method for histologic grading. , 1972, Journal of the National Cancer Institute.

[6]  D. Rall,et al.  Studies on the chemotherapy of experimental brain tumors: development of an experimental model. , 1970, Cancer research.

[7]  Brem.  Angiogenesis and Cancer Control: From Concept to Therapeutic Trial. , 1999, Cancer control : journal of the Moffitt Cancer Center.

[8]  B. Scheithauer,et al.  Histopathology, classification, and grading of gliomas , 1995, Glia.

[9]  R. Amirnovin,et al.  Vascular Apoptosis and Involution in Gliomas Precede Neovascularization: A Novel Concept for Glioma Growth and Angiogenesis , 2000, Laboratory Investigation.

[10]  B. Rosen,et al.  High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part II: Experimental comparison and preliminary results , 1996, Magnetic resonance in medicine.

[11]  P. Wesseling,et al.  Angiogenesis in brain tumors; pathobiological and clinical aspects , 1997, Journal of Neuro-Oncology.

[12]  E. Holland,et al.  Brain tumor animal models: importance and progress. , 2001, Current opinion in oncology.

[13]  E. Oldfield,et al.  Expression and modulation of major histocompatibility antigens on murine primary brain tumor in vitro. , 1991, Journal of neurosurgery.

[14]  G. Johnson,et al.  Dynamic contrast-enhanced T2*-weighted MR imaging of tumefactive demyelinating lesions. , 2001, AJNR. American journal of neuroradiology.

[15]  J. Folkman,et al.  The role of angiogenesis in tumor growth. , 1992, Seminars in cancer biology.

[16]  Erwin G. Van Meir,et al.  Glomeruloid microvascular proliferation orchestrated by VPF/VEGF: a new world of angiogenesis research. , 2001, The American journal of pathology.

[17]  E F Halpern,et al.  Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. , 1994, Radiology.

[18]  G Le Duc,et al.  Use of T2‐weighted susceptibility contrast MRI for mapping the blood volume in the glioma‐bearing rat brain , 1999, Magnetic resonance in medicine.

[19]  A P Pathak,et al.  MR‐derived cerebral blood volume maps: Issues regarding histological validation and assessment of tumor angiogenesis , 2001, Magnetic resonance in medicine.

[20]  G Johnson,et al.  Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging. , 1999, Radiology.

[21]  V M Runge,et al.  Cerebral hemodynamics and cerebral blood volume: MR assessment using gadolinium contrast agents and T1-weighted Turbo-FLASH imaging. , 1992, AJNR. American journal of neuroradiology.

[22]  G. Semenza,et al.  Molecular Events Implicated in Brain Tumor Angiogenesis and Invasion , 2000, Pediatric Neurosurgery.

[23]  A M Peters,et al.  Fundamentals of tracer kinetics for radiologists. , 1998, The British journal of radiology.

[24]  K. Plate,et al.  Vascular morphology and angiogenesis in glial tumors. , 1995, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.